Trial intelligence / Profile preview

Local sodium thiosulfate injections for ectopic calcifications or ossifications (pilot study)

2018-001978-22Phase 2Active

Sponsor
CHU de Limoges
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of sodium thiosulfate in calcinosis and ectopic ossification (HO) (3 arms), sponsored by CHU de Limoges. Primary endpoint: Primary: Percentage change in calcification/ossification volume from M6 to M12. Started Sep 2018; status: active.

02

Drugs

sodium thiosulfate
03

Conditions

calcinosisectopic ossification (HO)

Beyond the preview

Go deeper on 2018-001978-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-001978-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call